Camelidae and Cervidae West Nile Encephalomyelitis – NAVLE Study Guide

Overview and Clinical Importance

West Nile virus (WNV) is an arthropod-borne flavivirus that causes neurological disease in multiple mammalian species, including camelids (llamas, alpacas) and cervids (deer, elk, reindeer, moose). First isolated in Uganda in 1937, WNV was introduced to North America in 1999 and has since become endemic throughout the Americas. WNV infection in camelids and cervids represents an important differential diagnosis for veterinarians evaluating neurological disease during mosquito season.

Camelids and cervids are considered dead-end hosts, meaning they develop insufficient viremia to transmit the virus back to mosquito vectors. However, clinical disease can be severe, and mortality rates in neurologically affected animals range from 30-50%. Understanding the pathogenesis, clinical presentation, and management of WNV encephalomyelitis in these species is essential for NAVLE and BCSE examination success.

Etiology and Viral Characteristics

Viral Classification

West Nile virus belongs to the family Flaviviridae, genus Flavivirus. It is closely related to other encephalitic flaviviruses including Japanese encephalitis virus, St. Louis encephalitis virus, and Murray Valley encephalitis virus. The virus is a single-stranded, positive-sense RNA virus with an enveloped, icosahedral structure measuring approximately 45-50 nm in diameter.

West Nile Virus Characteristics

Transmission and Epidemiology

Transmission Cycle

WNV is maintained in nature through an enzootic cycle between mosquito vectors and avian reservoir hosts. The primary vectors are Culex species mosquitoes, including Cx. pipiens (Northern house mosquito), Cx. quinquefasciatus (Southern house mosquito), and Cx. tarsalis (Western encephalitis mosquito). Birds, particularly corvids (crows, blue jays) and passerines (American robins, house sparrows), serve as amplifying hosts, developing high-titer viremia that allows efficient transmission back to feeding mosquitoes.

Seasonality and Geographic Distribution

In temperate climates, WNV transmission peaks during late summer and early fall (July-October) when mosquito populations are highest. In endemic areas, WNV infection rates in some camelid herds have reached as high as 80% based on serological surveys. The virus is now endemic throughout the continental United States, Canada, Mexico, Central and South America, Europe, Africa, the Middle East, and parts of Asia.

Species Susceptibility

Camelidae

Alpacas appear to be more clinically susceptible to WNV than llamas, though both species can be affected. Camelids are considered less susceptible to developing clinical disease than horses, but neurological disease when it occurs can be severe and sometimes fatal. During the 2003 Colorado outbreak, multiple alpacas developed WNV encephalitis, with confirmed cases reported from July through September coinciding with peak mosquito season.

Cervidae

Fatal WNV infection has been documented in white-tailed deer (Odocoileus virginianus) and reindeer (Rangifer tarandus). Most cervids develop subclinical infection with seroconversion, but sporadic clinical encephalitis cases occur during periods of intense local viral activity. Serological surveys demonstrate widespread exposure in wild deer populations in endemic areas.

Species Susceptibility Comparison

Pathogenesis

Following mosquito inoculation, WNV initially replicates in dendritic cells and keratinocytes at the bite site. The virus then disseminates to regional lymph nodes and subsequently enters the bloodstream, producing viremia. The incubation period is typically 3-15 days.

Neuroinvasion occurs through several mechanisms: direct viral entry across the blood-brain barrier, retrograde axonal transport along peripheral nerves, and possibly through olfactory neurons. Once in the CNS, WNV demonstrates neurotropism with preferential infection of neurons in the brainstem, basal ganglia, thalamus, and anterior horn cells of the spinal cord.

Clinical Signs

Camelid Clinical Presentation

Clinical signs in camelids typically develop acutely and may include:

• Fever (may be transient or absent by time of neurological signs)
• Anorexia and depression
• Head tremors (characteristic early sign)
• Asymmetric ataxia (stumbling, incoordination)
• Neck muscle contracture (torticollis)
• Recumbency with inability to rise
• Vocalization indicating pain
• Muscle fasciculations and proprioceptive deficits

Cervid Clinical Presentation

In cervids, clinical WNV infection is less commonly observed but may include:

• Progressive ataxia and incoordination
• Head and body tremors
• Hindlimb weakness
• Behavioral changes (loss of fear, depression)
• Recumbency and death

Diagnosis

Ante-mortem Diagnosis

Serology

The primary ante-mortem diagnostic method is detection of WNV-specific IgM antibodies in serum or cerebrospinal fluid (CSF). IgM antibodies typically appear 3-8 days after onset of illness and persist for 30-90 days. Detection of IgM in CSF provides strong evidence of CNS infection.

• IgM-capture ELISA: Test of choice for acute infection
• Plaque reduction neutralization test (PRNT): Confirmatory test to differentiate from other flaviviruses
• Paired serology: Four-fold rise in IgG titers between acute and convalescent samples confirms diagnosis

Cerebrospinal Fluid Analysis

CSF analysis typically reveals:

• Lymphocytic pleocytosis: Elevated white cell count (neutrophils may predominate early)
• Elevated protein: Increased total protein concentration
• Normal glucose: Usually within normal limits
• WNV IgM in CSF: Confirms neuroinvasive disease

Post-mortem Diagnosis

Histopathology

Characteristic histopathological findings include:

• Nonsuppurative meningoencephalomyelitis: Lymphoplasmacytic inflammation
• Perivascular cuffing: Lymphocytes and plasma cells surrounding blood vessels
• Microglial nodules (glial nodules): Clusters of activated microglia
• Neuronal necrosis and neuronophagia: Neuronal death with phagocytosis
• Gliosis: Reactive astrocyte proliferation

Molecular and Immunohistochemical Diagnosis

• RT-PCR: Detection of viral RNA in brain tissue, blood, or CSF
• Immunohistochemistry (IHC): Detection of WNV antigen in neurons and glial cells
• Virus isolation: Culture from brain tissue (research/reference laboratories)

Diagnostic Approach Summary

Differential Diagnosis

The differential diagnosis for neurological disease in camelids and cervids includes multiple conditions:

Treatment and Management

There is no specific antiviral therapy for WNV infection. Treatment is supportive and aimed at reducing CNS inflammation, maintaining hydration, and preventing secondary complications.

Supportive Care

• Fluid therapy: IV or SC fluids to maintain hydration
• Nutritional support: Assisted feeding if necessary
• Soft bedding: Prevent decubital ulcers in recumbent animals
• Sling support: For animals unable to stand

Pharmacological Treatment Options

Prognosis

Prognosis depends on severity of clinical signs:

• Ambulatory animals: Fair to good prognosis (survival rate approximately 80-90%)
• Recumbent animals: Poor prognosis (survival rate less than 50%)
• Animals requiring sling support: Guarded prognosis

Survivors may have persistent neurological deficits including weakness, ataxia, and personality changes that can last for months or be permanent.

Prevention

Vaccination

No WNV vaccines are currently licensed for camelids or cervids. However, equine WNV vaccines have been used off-label in these species with apparent safety:

• Killed equine vaccine: THREE intramuscular doses at 3-4 week intervals for camelids (vs. two doses in horses)
• Canarypox-vectored vaccine: Two doses at 3-week intervals; no adverse reactions reported
• Annual boosters: Administer before mosquito season (spring)

Mosquito Control

• Eliminate standing water: Remove mosquito breeding sites (troughs, buckets, tires)
• House animals during peak activity: Mosquitoes are most active at dusk and dawn
• Use fans in barns: Air movement reduces mosquito activity
• Insect repellents: Permethrin-based products on animals and premises
• Minimize lighting in barns: Lights attract insects during evening hours

Regulatory Considerations

West Nile virus is a notifiable disease to the World Organisation for Animal Health (WOAH/OIE) and is reportable in many jurisdictions. Positive cases should be reported to state and federal veterinary authorities.